Elevance Health
1,473 hedge funds and large institutions have $57.1B invested in Elevance Health in 2026 Q1 according to their latest regulatory filings, with 145 funds opening new positions, 487 increasing their positions, 646 reducing their positions, and 210 closing their positions.
89% more call options, than puts
Call options by funds: $550M | Put options by funds: $291M
2.67% less ownership
Funds ownership: 91% → 88.33% (-2.7%)
5% less funds holding
Funds holding: 1,558 → 1,473 (-85)
20% less capital invested
Capital invested by funds: $71B → $57.1B (-$13.9B)
25% less repeat investments, than reductions
Existing positions increased: 487 | Existing positions reduced: 646
31% less first-time investments, than exits
New positions opened: 145 | Existing positions closed: 210
35% less funds holding in top 10
Funds holding in top 10: 31 → 20 (-11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
+$525M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$300M |
| 3 |
SG Americas Securities
New York
|
+$184M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$168M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$163M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$887M |
| 2 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$349M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$265M |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$195M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$176M |
ELV Hedge Fund Activity: Q1 2026 in Review
1,473 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2026, worth a combined $57.1B — down 20% from $71B a quarter earlier.
Sellers outnumbered buyers: 210 funds closed out of ELV and 145 opened new positions — a net loss of 65 holders — while 646 trimmed existing stakes and 487 added.
The largest buyer was Amundi, adding an estimated $525M. The largest seller was T. Rowe Price Associates, cutting an estimated $887M.
- 1,473 institutional investors held Elevance Health (ELV) as of Q1 2026, down from 1,558 in Q4 2025.
- Funds reported $57.1B of Elevance Health stock for Q1 2026, down 20% quarter-over-quarter.
- 145 funds opened new Elevance Health positions in Q1 2026 and 210 closed out, a net change of -65 holders.
- The largest Elevance Health buyer in Q1 2026 was Amundi, an estimated $525M added.
- The largest Elevance Health seller in Q1 2026 was T. Rowe Price Associates, an estimated $887M sold.
Based on aggregated 13F filings for Q1 2026.